Drug-disease interactions

narrative review of aspirin in gastric ulcer

Ezekiel Uba Nwose, Kwang Choon Yee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

INTRODUCTION: Drug-disease interactions include the impact of a drug and a particular disease condition on each other. However, the current practice in addressing drug-disease interaction is unbalanced and mostly limited to how the drug worsens the disease or health condition.

AREAS COVERED: Aspirin and gastric ulcer interaction are used as an example to illustrate this concept, especially the narration of how disease affects drug efficacy. The number of molecules that make up 100 mg of aspirin is identified with a view to discuss the pharmacokinetics, especially in terms of absorption and distribution. Using hypothetical scenarios, the pharmacodynamics in co-morbidities that could involve gastric ulcer and aspirin are also discussed.

EXPERT OPINION: There seems to be oversight in definition and description of drug-disease interaction, which is often limited to 'how drug exacerbates disease'. The implication of this limited definition is that the discussions, research and teaching of the topic either lacks information, or are not clear on 'how disease affects drug efficacy'. For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely discussed in preference to the probability of gastro-intestinal bleeding side-effect.

Original languageEnglish
Pages (from-to)1081-7
Number of pages7
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume12
Issue number9
DOIs
Publication statusPublished - Sep 2016
Externally publishedYes

Fingerprint

Stomach Ulcer
Drug Interactions
Aspirin
Pharmaceutical Preparations
Narration
Pharmacodynamics
Pharmacokinetics
Therapeutic Uses
Biological Availability
Teaching
Health
Hemorrhage
Morbidity
Molecules
Research

Cite this

@article{e57cba07955c45a4b288f92903b396d8,
title = "Drug-disease interactions: narrative review of aspirin in gastric ulcer",
abstract = "INTRODUCTION: Drug-disease interactions include the impact of a drug and a particular disease condition on each other. However, the current practice in addressing drug-disease interaction is unbalanced and mostly limited to how the drug worsens the disease or health condition.AREAS COVERED: Aspirin and gastric ulcer interaction are used as an example to illustrate this concept, especially the narration of how disease affects drug efficacy. The number of molecules that make up 100 mg of aspirin is identified with a view to discuss the pharmacokinetics, especially in terms of absorption and distribution. Using hypothetical scenarios, the pharmacodynamics in co-morbidities that could involve gastric ulcer and aspirin are also discussed.EXPERT OPINION: There seems to be oversight in definition and description of drug-disease interaction, which is often limited to 'how drug exacerbates disease'. The implication of this limited definition is that the discussions, research and teaching of the topic either lacks information, or are not clear on 'how disease affects drug efficacy'. For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely discussed in preference to the probability of gastro-intestinal bleeding side-effect.",
keywords = "Aspirin, Gastrointestinal Hemorrhage, Humans, Platelet Aggregation Inhibitors, Research Design, Stomach Ulcer, Tissue Distribution, Journal Article, Review",
author = "Nwose, {Ezekiel Uba} and Yee, {Kwang Choon}",
year = "2016",
month = "9",
doi = "10.1080/17425255.2016.1201064",
language = "English",
volume = "12",
pages = "1081--7",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Taylor and Francis Ltd.",
number = "9",

}

Drug-disease interactions : narrative review of aspirin in gastric ulcer. / Nwose, Ezekiel Uba; Yee, Kwang Choon.

In: Expert Opinion on Drug Metabolism and Toxicology, Vol. 12, No. 9, 09.2016, p. 1081-7.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug-disease interactions

T2 - narrative review of aspirin in gastric ulcer

AU - Nwose, Ezekiel Uba

AU - Yee, Kwang Choon

PY - 2016/9

Y1 - 2016/9

N2 - INTRODUCTION: Drug-disease interactions include the impact of a drug and a particular disease condition on each other. However, the current practice in addressing drug-disease interaction is unbalanced and mostly limited to how the drug worsens the disease or health condition.AREAS COVERED: Aspirin and gastric ulcer interaction are used as an example to illustrate this concept, especially the narration of how disease affects drug efficacy. The number of molecules that make up 100 mg of aspirin is identified with a view to discuss the pharmacokinetics, especially in terms of absorption and distribution. Using hypothetical scenarios, the pharmacodynamics in co-morbidities that could involve gastric ulcer and aspirin are also discussed.EXPERT OPINION: There seems to be oversight in definition and description of drug-disease interaction, which is often limited to 'how drug exacerbates disease'. The implication of this limited definition is that the discussions, research and teaching of the topic either lacks information, or are not clear on 'how disease affects drug efficacy'. For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely discussed in preference to the probability of gastro-intestinal bleeding side-effect.

AB - INTRODUCTION: Drug-disease interactions include the impact of a drug and a particular disease condition on each other. However, the current practice in addressing drug-disease interaction is unbalanced and mostly limited to how the drug worsens the disease or health condition.AREAS COVERED: Aspirin and gastric ulcer interaction are used as an example to illustrate this concept, especially the narration of how disease affects drug efficacy. The number of molecules that make up 100 mg of aspirin is identified with a view to discuss the pharmacokinetics, especially in terms of absorption and distribution. Using hypothetical scenarios, the pharmacodynamics in co-morbidities that could involve gastric ulcer and aspirin are also discussed.EXPERT OPINION: There seems to be oversight in definition and description of drug-disease interaction, which is often limited to 'how drug exacerbates disease'. The implication of this limited definition is that the discussions, research and teaching of the topic either lacks information, or are not clear on 'how disease affects drug efficacy'. For example, gastric ulcer has the potential to enhance absorption, bioavailability and therapeutic effects of aspirin, but this is rarely discussed in preference to the probability of gastro-intestinal bleeding side-effect.

KW - Aspirin

KW - Gastrointestinal Hemorrhage

KW - Humans

KW - Platelet Aggregation Inhibitors

KW - Research Design

KW - Stomach Ulcer

KW - Tissue Distribution

KW - Journal Article

KW - Review

U2 - 10.1080/17425255.2016.1201064

DO - 10.1080/17425255.2016.1201064

M3 - Article

VL - 12

SP - 1081

EP - 1087

JO - Expert Opinion on Drug Metabolism and Toxicology

JF - Expert Opinion on Drug Metabolism and Toxicology

SN - 1742-5255

IS - 9

ER -